These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22857802)

  • 1. Comment on Monte Carlo calculation of the dose distributions of two ¹⁰⁶Ru eye applicators [Radiother Oncol 49 (1998) 191-196].
    Brualla L; Sempau J; Sauerwein W
    Radiother Oncol; 2012 Aug; 104(2):267-8. PubMed ID: 22857802
    [No Abstract]   [Full Text] [Related]  

  • 2. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.
    Sánchez-Reyes A; Tello JI; Guix B; Salvat F
    Radiother Oncol; 1998 Nov; 49(2):191-6. PubMed ID: 10052886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry of 106Ru eye applicators with a p-type silicon detector.
    Lax I
    Phys Med Biol; 1991 Jul; 36(7):963-72. PubMed ID: 1886930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plexiglass replicas for optimizing selection and site of ruthenium 106 applicators].
    Menapace R
    Klin Monbl Augenheilkd; 1990 Jan; 196(1):40-2. PubMed ID: 2313993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanomas of the choroid and ruthenium applicators.
    Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ
    Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
    Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
    Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patch source model for treatment planning of ruthenium ophthalmic applicators.
    Astrahan MA
    Med Phys; 2003 Jun; 30(6):1219-28. PubMed ID: 12852546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of ruthenium-106 eye applicators.
    Davelaar J; Schaling DF; Hennen LA; Broerse JJ
    Med Phys; 1992; 19(3):691-4. PubMed ID: 1508109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium applicators in the treatment of choroidal melanomas.
    Van Hijfte R; Verbraeken H; De Laey JJ
    Bull Soc Belge Ophtalmol; 1987; 224():51-8. PubMed ID: 3509023
    [No Abstract]   [Full Text] [Related]  

  • 11. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroidal metastasis of cutaneous malignant melanoma treated by ruthenium-106 plaque irradiation.
    Anteby I; Axer-Siegel R; Pe'er J
    Ann Ophthalmol; 1993 Sep; 25(9):339-41. PubMed ID: 8297070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium-106 brachytherapy.
    Pe'er J
    Dev Ophthalmol; 2012; 49():27-40. PubMed ID: 22042011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal melanoma suspect. Conservative treatment and evolution. Case report.
    Zemba M; Malciolu RA
    Rom J Ophthalmol; 2016; 60(4):264-269. PubMed ID: 29450360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
    Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of melanomas of the choroid with 106 Ru/106 Rh applicators. Preliminary results].
    Grange JD; Bonnet M; Bievelez B; Gérard JP; Philippon B; Burillon C
    Bull Soc Ophtalmol Fr; 1985 Dec; 85(12):1333-7. PubMed ID: 3843206
    [No Abstract]   [Full Text] [Related]  

  • 17. Optical coherence tomography angiography-based analysis of intrinsic vasculature in juxtapapillary melanoma after ruthenium-106 plaque brachytherapy.
    Shanmugam PM; Konana VK; Ramanjulu R; Mishra KCD; Sagar P; Kumar D
    Indian J Ophthalmol; 2019 Dec; 67(12):2086-2088. PubMed ID: 31755470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curietherapy using a ruthenium and iridium disk in the treatment of choroid melanoma].
    Gérard JP; Grange JD; Romestaing P; Sentenac I; De Laroche G; Montbarbon X; Mahe M; Salerno N; Baude JP; Bonnet M
    Ann Radiol (Paris); 1989; 32(2):107-11. PubMed ID: 2757334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results and implications of high-resolution surface dosimetry of ruthenium-106 eye applicators.
    Menapace R; Binder W; Chiari A
    Ophthalmologica; 1992; 204(2):93-100. PubMed ID: 1594188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimizing target volume assessment in irradiation of intraocular melanomas with ruthenium applicators].
    Poier E; Langmann G; Leitner H; Vidic B
    Fortschr Ophthalmol; 1991; 88(2):158-60. PubMed ID: 1855736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.